Kyndryl Partners with Dr Reddys to Automate Global IT Operations

Kyndryl, a top mission-critical enterprise technology services company, has entered into a strategic association with Dr. Reddy's Laboratories, a leading Indian multinational pharmaceutical firm, to transform and simplify the latter's worldwide IT

NPPA Permits Torrent to Shift Drug Production from Akums to Sikkim

At the retail price previously authorized by the National Pharmaceutical Pricing Authority ( NPPA), Torrent Pharmaceuticals has been permitted to move the manufacturing of its combination medication for nutritional

API Prices Plunge, Easing Costs for Indian Pharma Manufacturers

A significant drop is being seen in the prices of active pharmaceutical ingredients (API) used for manufacturing drugs, bringing relief to India's pharmaceutical industry. China is largely depended upon the pharma industry for sourcing APIs

BioNTech, BMS Partner to Advance BNT327 in Solid Tumor Cancers

An agreement has been reached between BioNTech and Bristol Myers Squibb for the worldwide co-development and co-commercialization of BioNTech's investigational bispecific antibody BNT327 across a variety of solid tumor types.

ASPA marks World Anti-Counterfeiting Day with major industry initiative

The Authentication Solution Providers’ Association (ASPA) ahead of World Anti-Counterfeiting Day, has commissioned the second edition of its flagship industry report, ‘State of Counterfeiting in India – 2025

New Treatment Aumolertinib Approved for EGFR-Positive NSCLC

Aumolertinib (Aumseqa) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for adult patients with non-small cell lung cancer (NSCLC).

Gland Pharma Received Approval from USFDA for its Blood Pressure Drug

Gland Pharma Limited saw its shares rise nearly 3% during intraday trading on Wednesday following the announcement of a major regulatory accomplishment...

India to Boost its PLI Initiative for Drug Manufacturing

India is about to give a significant boost to its production-linked incentive (PLI) scheme for pharmaceuticals as it seeks to establish a stronger domestic production of key starting materials (KSMs)...

Sun Pharma to Invest $100M in Specialty Drug Launches This Fiscal

According to Chairman and Managing Director Dilip Shanghvi, Sun Pharmaceutical Industries has secured a USD 100 million investment to commercialize innovative pharmaceuticals in the current fiscal year

India Sets New Date for MEG Anti-Dumping Probe Hearing

The Directorate General of Trade Remedies (DGTR) has rescheduled the oral hearing for its ongoing anti-dumping investigation into imports of mono ethylene glycol (MEG) from Kuwait, Saudi Arabia, and Singapore...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.